Richard McGowan

Richard McGowan

Auto-generated profile, based on publicly available information

Richard McGowan

Research Librarian, Adjunct Assistant Professor, Department of Epidemiology and Health Promotion, New York University College of Dentistry, New York, New York, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Archives of Oral Biology
Verified
Journal Article
Closed access
CDColin Dawes
Colin Dawes
APA.M.L. Pedersen
A.M.L. Pedersen
AVA. Villa
A. Villa
JEJ. Ekström
J. Ekström
Gordon ProctorGordon Proctor
Gordon Proctor
AWA. Wolff
A. Wolff

16 November 2016 in Drugs in R&D
Verified
Journal Article
Open access
PDF file
AWAndy Wolff
Andy Wolff
RJRevan Kumar Joshi
Revan Kumar Joshi
JEJörgen Ekström
Jörgen Ekström
DADoron Aframian
Doron Aframian
APAnne Marie Lynge Pedersen
Anne Marie Lynge Pedersen
CDColin Dawes
Colin Dawes
Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist. Objective Our objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. Data Sources Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the above-mentioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices. Limitations While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search. Conclusions We compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.

1 September 2009 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
JRJohn Richmond
John Richmond
DHDavid Hunter
David Hunter
JIJay Irrgang
Jay Irrgang
MJMorgan H. Jones
Morgan H. Jones
BLBruce Levy
Bruce Levy
RMRichard McGowan
Richard McGowan
The clinical practice guideline was explicitly developed to include only treatments less invasive than knee replacement (ie, arthroplasty). Patients with symptomatic osteoarthritis of the knee are to be encouraged to participate in self-management educational programs and to engage in self-care, as well as to lose weight and engage in exercise and quadriceps strengthening. The guideline recommends taping for short-term relief of pain as well as analgesics and intra-articular corticosteroids, but not glucosamine and/or chondroitin. Patients need not undergo needle lavage or arthroscopy with débridement or lavage. Patients may consider partial meniscectomy or loose body removal or realignment osteotomy, as conditions warrant. Use of a free-floating interpositional device should not be considered for symptomatic unicompartmental osteoarthritis of the knee. Lateral heel wedges should not be prescribed for patients with symptomatic medial compartmental osteoarthritis of the knee. The work group was unable either to recommend or not recommend the use of braces with either valgus- or varus-directing forces for patients with medial unicompartmental osteoarthritis; the use of acupuncture or of hyaluronic acid; or osteotomy of the tibial tubercle for isolated symptomatic patellofemoral osteoarthritis.

1 April 2010 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JRJohn Richmond
John Richmond
DHDavid Hunter
David Hunter
JIJames Irrgang
James Irrgang
MJMorgan H Jones
Morgan H Jones
LSLynn Snyder-Mackler
Lynn Snyder-Mackler
RMRichard McGowan
Richard McGowan

1 October 2017 in Reproductive Toxicology
Verified
Journal Article
Closed access
MGMarya Ghazipura
Marya Ghazipura
RMRichard McGowan
Richard McGowan
AAAlan A. Arslan
Alan A. Arslan
THTanzib Hossain
Tanzib Hossain

22 May 2015 in Clinical Oral Investigations
Verified
Journal Article
Open access
PDF file
AVAlessandro Villa
Alessandro Villa
AWAndy Wolff
Andy Wolff
DADoron Aframian
Doron Aframian
AVArjan Vissink
Arjan Vissink
JEJörgen Ekström
Jörgen Ekström
APAnne Marie Lynge Pedersen
Anne Marie Lynge Pedersen
Medication-induced salivary gland dysfunction (MISGD) causes significant morbidity resulting in decreased quality of life. This systematic review assessed the literature on the prevalence, diagnosis, treatment, and prevention of MISGD. Electronic databases were searched for articles related to MISGD through June 2013. Four independent reviewers extracted information regarding study design, study population, interventions, outcomes, and conclusions for each article. Only papers with acceptable degree of relevance, quality of methodology, and strength of evidence were retained for further analysis. There were limited data on the epidemiology of MISGD. Furthermore, various methods were used to assess salivary flow rate or xerostomia. Preventive and therapeutic strategies included substitution of medications, oral, or systemic therapy with sialogogues, use of saliva substitutes or of electro-stimulating devices. Although there are promising approaches to improve salivary gland function, most studies are characterized by small numbers and heterogeneous methods. Physicians and dentists should identify the medications associated with xerostomia and salivary gland dysfunction through a thorough medical history. Preferably, health care providers should measure the unstimulated and stimulated whole salivary flow rates of all their patients so that these values can be used as a baseline to rate the complaints of patients who subsequently claim to experience xerostomia or salivary gland dysfunction as well as the possibilities of effectively treating this condition. MISGD remains a major burden for the population. This systematic review provides a contemporary in-depth description of the diagnosis and treatment of MISGD.